Call Options

13 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.61 - $2.73 $55,384 - $93,912
34,400 New
34,400 $56,000
Q1 2022

May 17, 2022

BUY
$3.34 - $5.56 $118,570 - $197,380
35,500 Added 64.78%
90,300 $419,000
Q4 2021

Feb 15, 2022

BUY
$4.81 - $11.92 $131,313 - $325,416
27,300 Added 99.27%
54,800 $274,000
Q3 2021

Nov 16, 2021

BUY
$11.34 - $21.37 $142,884 - $269,262
12,600 Added 84.56%
27,500 $331,000
Q2 2021

Aug 16, 2021

BUY
$19.4 - $28.71 $79,540 - $117,711
4,100 Added 37.96%
14,900 $315,000
Q1 2021

May 18, 2021

SELL
$25.12 - $36.89 $2.14 Million - $3.14 Million
-85,100 Reduced 88.74%
10,800 $303,000
Q4 2020

Feb 17, 2021

BUY
$24.2 - $35.76 $537,240 - $793,872
22,200 Added 30.12%
95,900 $2.49 Million
Q3 2020

Nov 17, 2020

SELL
$31.18 - $52.71 $1.01 Million - $1.71 Million
-32,400 Reduced 30.54%
73,700 $2.74 Million
Q2 2020

Aug 17, 2020

BUY
$30.04 - $51.31 $2.85 Million - $4.87 Million
94,900 Added 847.32%
106,100 $5.44 Million
Q4 2019

Feb 14, 2020

BUY
$35.4 - $59.82 $38,940 - $65,802
1,100 Added 10.89%
11,200 $668,000
Q3 2018

Nov 14, 2018

BUY
$40.74 - $51.41 $114,072 - $143,948
2,800 Added 38.36%
10,100 $448,000
Q1 2018

May 15, 2018

BUY
$65.94 - $80.76 $46,158 - $56,532
700 Added 10.61%
7,300 $528,000
Q3 2017

Nov 14, 2017

BUY
$43.8 - $52.77 $289,080 - $348,282
6,600
6,600 $331,000

Others Institutions Holding ESPR

About Esperion Therapeutics, Inc.


  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $155M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.